Dhanvantri Jeevan Rekha Ltd Stock Price Today (NSE: ZDHJERK)
Fundamental Score
Dhanvantri Jeevan Rekha Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Dhanvantri Jeevan Rekha Ltd share price today is ₹25.01, up +0.00% on NSE/BSE as of 17 July 2026. Dhanvantri Jeevan Rekha Ltd (ZDHJERK) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹11.19 (Cr). The 52-week high for ZDHJERK share price is ₹35.86 and the 52-week low is ₹19.00. At a P/E ratio of 27.98x, ZDHJERK is currently trading below its industry average P/E of 42.23x. The company has a Return on Equity (ROE) of 3.88% and a debt-to-equity ratio of 0.00.
Dhanvantri Jeevan Rekha Ltd Share Price Chart — NSE/BSE Historical Performance
Dhanvantri Jeevan Rekha Ltd share price chart: -8.79% return over the past month. 52-week high ₹35.86, 52-week low ₹19.00.
Dhanvantri Jeevan Rekha Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹25.01 | ₹25.01 | ₹25.01 | ₹25.01 | 104.00 (Cr) | |
| ₹25.02 | ₹25.02 | ₹25.01 | ₹25.01 | 13.00 (Cr) | |
| ₹26.32 | ₹26.32 | ₹26.32 | ₹26.32 | 553.00 (Cr) | |
| ₹27.52 | ₹27.52 | ₹27.52 | ₹27.52 | 327.00 (Cr) | |
| ₹28.90 | ₹28.90 | ₹28.90 | ₹28.90 | 2.00 (Cr) | |
| ₹27.34 | ₹30.00 | ₹27.34 | ₹28.90 | 108.00 (Cr) | |
| ₹28.78 | ₹28.79 | ₹28.77 | ₹28.77 | 232.00 (Cr) | |
| ₹27.50 | ₹27.50 | ₹27.40 | ₹27.42 | 110.00 (Cr) | |
| ₹27.61 | ₹27.61 | ₹26.90 | ₹26.90 | 174.00 (Cr) | |
| ₹26.38 | ₹26.38 | ₹25.14 | ₹26.30 | 23.00 (Cr) |
Dhanvantri Jeevan Rekha Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹25.01 | ₹25.01 | ₹25.01 | ₹25.01 | +0.00% | |
| ₹26.38 | ₹30.00 | ₹25.01 | ₹25.01 | -5.19% | |
| ₹24.50 | ₹25.14 | ₹21.35 | ₹25.14 | +2.61% | |
| ₹25.75 | ₹27.70 | ₹22.30 | ₹24.50 | -4.85% | |
| ₹24.55 | ₹25.70 | ₹22.40 | ₹24.74 | +0.77% | |
| ₹24.21 | ₹28.36 | ₹24.21 | ₹25.04 | +3.43% | |
| ₹27.59 | ₹27.59 | ₹23.05 | ₹23.06 | -16.42% | |
| ₹30.00 | ₹35.86 | ₹23.80 | ₹27.59 | -8.03% | |
| ₹21.00 | ₹29.76 | ₹21.00 | ₹29.60 | +40.95% | |
| ₹21.50 | ₹23.45 | ₹20.30 | ₹21.00 | -2.33% | |
| ₹20.05 | ₹22.30 | ₹19.00 | ₹21.20 | +5.74% |
AI Research Briefing
Powered by Gemini · 2026-04-10
Micro-cap healthcare play with stretched valuation and weak financials; avoid until fundamentals improve.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search.
CORE STORY (THE REAL GAME)
Dhanvantri Jeevan Rekha is a micro-cap healthcare service provider operating a hospital in Meerut. The market appears to be pricing in potential growth in the Indian healthcare sector, but the company's small size and financial performance raise concerns.
- Healthcare sector growth potential
- Past positive price momentum
- Digital adoption in healthcare
- Significant order wins
- Earnings beat expectations
- Acquisition by a larger player
- Micro/SME cap - high liquidity risk
- Stretched valuation (P/E 94.5x vs. industry 39.28x)
- Weak profitability (ROE 5.2%, ROCE 5.82%)
No FII/DII activity. Promoter holding stable at 19.65%.
Healthcare sector in India is transitioning to a technology-driven ecosystem.
No - Free Cash Flow 5Y: ₹0.88 Cr
Company needs to demonstrate significant improvement in financial performance to justify current valuation. Focus on profitability and revenue growth.
Primary Thesis Risk
Inability to scale operations and improve profitability will lead to significant downside.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Dhanvantri Jeevan Rekha Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Dhanvantri Jeevan Rekha Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ZDHJERK across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Attractive Valuation (P/E: 27.98 vs Industry: 42.23)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (900.00%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (24.19%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (21.47% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (17.94% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (17.94% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Below-Average Return on Equity (3.88%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (3.88%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (4.25%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Low Promoter Commitment (19.65%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Dhanvantri Jeevan Rekha Ltd vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Dhanvantri Jeevan Rekha Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Dhanvantri Jeevan Rekha LtdDhanvantri Jeev...Selected✓ ZDHJERK • 531043 | 48.1/100 | ₹25.01₹25 | ₹11.19₹11.19 | 27.98Average 28.0 Average | 3.88%Poor 3.88% Poor | 3.88%Poor 3.88% Poor | 0.00Excellent 0.0 Excellent | 17.94%Excellent 17.94% Excellent | 21.47%Excellent 21.47% Excellent | 0.00% |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 57.7/100 | ₹1723.30₹1723 | ₹28908.91₹28908.91 | 55.39Average 55.4 Average | 22.30%Excellent 22.30% Excellent | 28.00%Excellent 28.00% Excellent | 0.08Excellent 0.1 Excellent | 12.33%Good 12.33% Good | 11.81%Good 11.81% Good | 0.81% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 67.8/100 | ₹1261.40₹1261 | ₹14307.85₹14307.85 | 82.71Average 82.7 Average | 19.74%Good 19.74% Good | 21.29%Excellent 21.29% Excellent | 0.44Excellent 0.4 Excellent | 15.47%Excellent 15.47% Excellent | 16.66%Excellent 16.66% Excellent | 0.14% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 57.9/100 | ₹571.65₹572 | ₹11858.49₹11858.49 | 60.38Average 60.4 Average | 13.81%Average 13.81% Average | 17.77%Good 17.77% Good | 0.15Excellent 0.1 Excellent | 1.46%Average 1.46% Average | 10.52%Good 10.52% Good | 0.35% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 31.9/100 | ₹549.05₹549 | ₹1777.47₹1777.47 | 17.31Average 17.3 Average | 10.89%Average 10.89% Average | 12.70%Average 12.70% Average | 0.54Good 0.5 Good | -11.13%Poor -11.13% Poor | 11.75%Good 11.75% Good | 0.50% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 60.3/100 | ₹1272.00₹1272 | ₹1079.13₹1079.13 | 18.42Average 18.4 Average | 19.77%Good 19.77% Good | 25.48%Excellent 25.48% Excellent | 0.01Excellent 0.0 Excellent | -12.44%Poor -12.44% Poor | -8.95%Poor -8.95% Poor | 0.31% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 39/100 | ₹301.45₹301 | ₹1035.54₹1035.54 | 539.34Average 539.3 Average | 0.29%Poor 0.29% Poor | -0.05%Poor -0.05% Poor | 0.04Excellent 0.0 Excellent | 16.91%Excellent 16.91% Excellent | 19.09%Excellent 19.09% Excellent | 0.00% |
49.4/100 | ₹245.70₹246 | ₹600.78₹600.78 | 20.55Average 20.6 Average | 19.92%Good 19.92% Good | 23.27%Excellent 23.27% Excellent | 0.31Excellent 0.3 Excellent | — — | — — | 0.00% | |
Aspira Pathlab & Diagnostics LimitedAspira Pathlab ... ASPIRA • 540788 | 11.9/100 | ₹86.00₹86 | ₹88.52₹88.52 | 1770.34Average 1770.3 Average | 0.51%Poor 0.51% Poor | 2.84%Poor 2.84% Poor | 0.27Excellent 0.3 Excellent | -48.50%Poor -48.50% Poor | 10.43%Good 10.43% Good | 0.00% |
Choksi Imaging LtdChoksi Imaging ... CHOKSI • 526546 | 36.3/100 | ₹174.55₹175 | ₹81.49₹81.49 | 54.33Average 54.3 Average | 6.10%Poor 6.10% Poor | 9.64%Poor 9.64% Poor | 1.20Average 1.2 Average | 20.80%Excellent 20.80% Excellent | 12.36%Good 12.36% Good | 0.00% |
Medinova Diagnostic Services IncMedinova Diagno... MEDINOV • 526301 | 49/100 | ₹43.45₹43 | ₹43.37₹43.37 | 20.17Average 20.2 Average | — — | 108.87%Excellent 108.87% Excellent | — — | 56.49%Excellent 56.49% Excellent | 5.66%Good 5.66% Good | 0.00% |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price28908.91 Cr
- Vijaya Diagnostic Centre Ltd share price14307.85 Cr
- Metropolis Healthcare Ltd share price11858.49 Cr
- Krsnaa Diagnostics Ltd share price1777.47 Cr
- 3B Blackbio Diagnostics Ltd share price1079.13 Cr
Dhanvantri Jeevan Rekha Ltd PE Ratio History
Historical price-to-earnings ratio for ZDHJERK — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.42 | ₹22.37 | 53.3x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Dhanvantri Jeevan Rekha Ltd Quarterly Performance
Latest quarterly metrics for ZDHJERK — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
24.19%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
900.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
21.47%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
17.94%
Compounded annual net profit growth over 5 years
Dhanvantri Jeevan Rekha Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ZDHJERK — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Dhanvantri Jeevan Rekha Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Dhanvantri Jeevan Rekha Ltd (ZDHJERK) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Dhanvantri Jeevan Rekha Ltd
About ZDHJERK (Dhanvantri Jeevan Rekha Ltd)
Dhanvantri Jeevan Rekha Ltd is a comprehensive healthcare service provider dedicated to offering a wide spectrum of medical solutions across India. With a strong commitment to pati...ent well-being, the organization focuses on delivering both diagnostic and therapeutic services designed to address diverse health needs. Their state-of-the-art facilities are equipped to support a variety of treatments, aiming to provide accessible and effective healthcare to the communities they serve. Beyond standard medical procedures, Dhanvantri Jeevan Rekha Ltd strives to incorporate advanced technologies and innovative practices to enhance the overall patient experience and improve health outcomes. The company is committed to delivering quality healthcare with compassion, making it a reliable source for medical requirements. The organization's strength lies in its array of specialty services, meticulously crafted to cater to specific medical disciplines. Departments like Cardiology, Gastroenterology, Neurology, and others, are staffed with experienced medical professionals utilizing advanced diagnostic equipment and the latest medical knowledge. This specialized approach allows for focused and effective treatment plans, tailored to individual patient needs. Further strengthening their diagnostic capabilities, Dhanvantri Jeevan Rekha Ltd offers a comprehensive range of diagnostic services, ensuring accurate and timely detection of ailments. This robust combination of specialty care and diagnostic expertise forms the foundation of their commitment to comprehensive patient management. At the heart of their interventional cardiology services is a sophisticated cath lab, enabling a wide range of procedures. This includes angiography, angioplasty, and pacemaker implantation, demonstrating the company's dedication to offering advanced cardiac care. The cath lab also provides valvuloplasty services. Dhanvantri Jeevan Rekha Ltd leverages its advanced facilities and skilled professionals to provide patients with access to critical cardiac interventions, playing a crucial role in improving cardiovascular health in the region. The focus on advanced technology and skilled medical professionals ensures that the organization remains at the forefront of cardiac care, delivering potentially life-saving treatments.
Company Details
Key Leadership
Corporate Events
ZDHJERK Share Price: Frequently Asked Questions
What is the current share price of Dhanvantri Jeevan Rekha Ltd?
Dhanvantri Jeevan Rekha Ltd (ZDHJERK) trades at ₹25.01 on NSE and BSE. Market cap ₹11.19 (Cr). Educational data only.
What is the P/E ratio of Dhanvantri Jeevan Rekha Ltd?
Dhanvantri Jeevan Rekha Ltd has a P/E of 27.98x vs industry average 42.23x.
What is the Bull Run score for Dhanvantri Jeevan Rekha Ltd?
Dhanvantri Jeevan Rekha Ltd has a Bull Run score of 48.1/100 based on 25+ financial parameters.
Does Dhanvantri Jeevan Rekha Ltd pay dividends?
Dhanvantri Jeevan Rekha Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Dhanvantri Jeevan Rekha Ltd?
Dhanvantri Jeevan Rekha Ltd has ROE of 3.88%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Dhanvantri Jeevan Rekha Ltd?
Dhanvantri Jeevan Rekha Ltd has debt-to-equity of 0.00.
Is Dhanvantri Jeevan Rekha Ltd a good investment?
Bull Run gives Dhanvantri Jeevan Rekha Ltd a score of 48.1/100. This is not investment advice — consult a SEBI-registered advisor.